Xin-Ling Wang Selected Research

Xin-Ling Wang Research Topics

5	Cataract (Cataracts) 01/2019 - 08/2015
2	Neoplasms (Cancer) 01/2018 - 04/2010
2	Hypertension (High Blood Pressure) 01/2010 - 10/2008
1	Neck Pain (Cervicalgia) 07/2018
1	Pain (Aches) 01/2018
1	Exanthema (Rash) 01/2018
1	Herpes Zoster 01/2018
1	Postherpetic Neuralgia 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Diabetes Mellitus 06/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2015
1	Carcinoma (Carcinomatosis) 02/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2012
1	Uterine Cervical Dysplasia 02/2012
1	Uterine Cervicitis (Cervicitis) 02/2012
1	Optic Neuritis (Retrobulbar Neuritis) 07/2010
1	Optic Atrophy 07/2010
1	Endometrial Neoplasms (Endometrial Cancer) 04/2010
1	Apnea 01/2010
1	Obstructive Sleep Apnea 01/2010
1	Epiretinal Membrane (Epiretinal Membranes) 06/2009
1	Hypertrophy 06/2009
1	Dyslipidemias (Dyslipidemia) 10/2008

3	Retinaldehyde (Retinal)IBA 06/2015 - 06/2009
2	Analgesics (Analgesic Drugs)IBA 07/2018 - 01/2018
2	Methylprednisolone FDA LinkGeneric 07/2018 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 07/2018
1	Local AnestheticsIBA 07/2018
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 07/2018
1	SteroidsIBA 07/2018
1	Ibuprofen (Motrin)FDA LinkGeneric 07/2018
1	Sirtuin 1IBA 01/2018
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2018
1	Biological ProductsIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Blood Glucose (Blood Sugar)IBA 08/2015
1	Advanced Glycation End ProductsIBA 06/2015
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2015
1	advanced glycation end products-bovine serum albuminIBA 06/2015
1	EnzymesIBA 02/2012
1	ImmunosorbentsIBA 02/2012
1	Vascular Endothelial Growth Factor CIBA 02/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2010
1	Neuropeptide YIBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Type 1 Angiotensin ReceptorIBA 10/2008
1	oxidized low density lipoproteinIBA 10/2008

1	Therapeutics 01/2018
1	Lenses 08/2015